1000-8179
2013 Issue 21
Pemetrexed and platinum as first-line chemotherapy for advanced lung adenocarcinoma:an observation of recent therapeutic effects and a safety profile
Xiaoxian YE;Ying YUAN;Hong SHEN
Xiaoxian YE;Ying YUAN;Hong SHEN
..............page:1324-1327
Clinical observations and outcomes of capecitabine-based regimens in treating Chinese patients with liver metastases from breast cancer
Jian YUE;Fei MA;Lingxiao ZHANG;Qiao LI;Ying FAN;Jiayu WANG;Qing LI;Ping ZHANG;Binghe XU
Jian YUE;Fei MA;Lingxiao ZHANG;Qiao LI;Ying FAN;Jiayu WANG;Qing LI;Ping ZHANG;Binghe XU
..............page:1304-1308
Meta-analysis of the safety of Yangzhengxiaoji capsule for the treatment of cancer and precancerosis
Kan XUE;Fei SHAN;Jiafu JI
Kan XUE;Fei SHAN;Jiafu JI
..............page:1318-1323
Identifying the genetic pattern of conventional fractionated and hypofractionated radiotherapy using whole genome expression microarray in a non-small-cell lung cancer cell line
Jian SUN;Ningbo LIU;Chenhui QU;Baohu WANG;Hua GUO;Ping WANG
Jian SUN;Ningbo LIU;Chenhui QU;Baohu WANG;Hua GUO;Ping WANG
..............page:1280-1283
Multi-disciplinary diagnosis and treatment of a malignant pheochromocytoma with multiple metastases
Yawen ZHENG;Xinwei ZHANG;Zhongli ZHAN;Zhaoxiang YE;Wengui XU;Peiguo WANG;Zhi GUO;Xin YAO;Guangru XIE;Dingzhi HUANG;Xiubao REN
Yawen ZHENG;Xinwei ZHANG;Zhongli ZHAN;Zhaoxiang YE;Wengui XU;Peiguo WANG;Zhi GUO;Xin YAO;Guangru XIE;Dingzhi HUANG;Xiubao REN
..............page:1332-1336
Axillary reverse mapping by dye method in 300 breast cancer patients
Dajun YU;Jun QIAN;Jing LI;Ke ZHANG
Dajun YU;Jun QIAN;Jing LI;Ke ZHANG
..............page:1296-1299
Research progress in molecular targeted therapy for gynecological cancer
Huijuan WU;Quan HAO
Huijuan WU;Quan HAO
..............page:1341-1343
Clinical characteristics and treatment of primary ovarian malignant lymphoma
Jing ZHAO;Huaqing WANG;Ping WANG
Jing ZHAO;Huaqing WANG;Ping WANG
..............page:1328-1331
Percutaneous microwave coagulation for treating peripheral non-small-cell lung cancer
Lingde KONG;Haibo LIU;Zhitao CHEN;Wei XIAO;Yuxia LIN;Ying CHEN;Liangming ZHU
Lingde KONG;Haibo LIU;Zhitao CHEN;Wei XIAO;Yuxia LIN;Ying CHEN;Liangming ZHU
..............page:1314-1317
Clinical significance of neutrophil and albumin pretreatments in nasopharyngeal carcinoma prognosis
Xiaofeng TANG;Lin ZHANG;Jiang LI
Xiaofeng TANG;Lin ZHANG;Jiang LI
..............page:1309-1313
Relationship of BRCA1 andβ-tubulinⅢmRNA expression with efficacy of taxanes for advanced esophageal carcinoma
Weimei JIANG;Wei YE;Hua JIANG;Zhixia ZHU
Weimei JIANG;Wei YE;Hua JIANG;Zhixia ZHU
..............page:1288-1291
..............page:1327-1327
Cisplatin-induced up-regulation and enrichment of BCRP and EHD2 on cell surface
Pan LI;Li PAN;Xin FU;Shaobin YANG;Jingwen FENG;Mingqiu HU;Guoguang YING
Pan LI;Li PAN;Xin FU;Shaobin YANG;Jingwen FENG;Mingqiu HU;Guoguang YING
..............page:1284-1287
..............page:1277-1279
tai er xing heng wen ji liu 2 li
fu yan ping ; wang wei
fu yan ping ; wang wei
..............page:1344-1344
Application of two methods of high-risk HPV detection in early screening of uterine cervical cancer
Menghui LI;Shixia LI;Juntian LIU
Menghui LI;Shixia LI;Juntian LIU
..............page:1300-1303
The role of tumor microenvironment in lymphangiogenesis
Yuyan LUO;Zhengfei HE;Xiaojun DAI
Yuyan LUO;Zhengfei HE;Xiaojun DAI
..............page:1337-1340
Clinical significance of Sipa1 expression in gastric cancer
Liangqing LI;Zhenmeng LIN;Dun PAN
Liangqing LI;Zhenmeng LIN;Dun PAN
..............page:1292-1295